Cargando…
Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion
Metformin hydrochloride (MET) sustained-release solid dispersions (SD) were prepared by the solvent evaporation and closed melt method, using compritol 888 ATO as the polymer with five different drug-carrier ratios. Characterization of solid dispersion was carried out by Fourier Transform Infrared (...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159272/ https://www.ncbi.nlm.nih.gov/pubmed/21897658 http://dx.doi.org/10.4103/0975-1483.83758 |
_version_ | 1782210439420051456 |
---|---|
author | Jagdale, SC Patil, SA Kuchekar, BS Chabukswar, AR |
author_facet | Jagdale, SC Patil, SA Kuchekar, BS Chabukswar, AR |
author_sort | Jagdale, SC |
collection | PubMed |
description | Metformin hydrochloride (MET) sustained-release solid dispersions (SD) were prepared by the solvent evaporation and closed melt method, using compritol 888 ATO as the polymer with five different drug-carrier ratios. Characterization of solid dispersion was carried out by Fourier Transform Infrared (FTIR) spectroscopy, ultraviolet (UV) spectroscopy, Differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD). The FTIR and UV studies suggested that no bond formation had occurred between the polymer and the drug. DSC and XPRD results ruled out any interaction or complex formation between the drug and the polymer. The formulated SD had acceptable physicochemical characters and SD with a 1 : 4 drug : Polymer ratio, which released the drug over an extended period of eight-to-ten hours. The data obtained from the in vitro release studies were fitted with various kinetic models and were found to follow the Korsmeyer-Peppas equation. The prepared SD showed good stability over the studied time period. The solvent evaporation method was found to be more helpful than the closed melt method, giving the sustained release action. The SD with a 1 : 4 ratio of drug to polymer, by the solvent evaporation method, was selected as the most effective candidate for the subsequent development of a well-timed, sustained-release dosage form of the drug. |
format | Online Article Text |
id | pubmed-3159272 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Medknow Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-31592722011-09-06 Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion Jagdale, SC Patil, SA Kuchekar, BS Chabukswar, AR J Young Pharm Pharmaceutics Metformin hydrochloride (MET) sustained-release solid dispersions (SD) were prepared by the solvent evaporation and closed melt method, using compritol 888 ATO as the polymer with five different drug-carrier ratios. Characterization of solid dispersion was carried out by Fourier Transform Infrared (FTIR) spectroscopy, ultraviolet (UV) spectroscopy, Differential scanning calorimetry (DSC), X-ray powder diffraction (XRPD). The FTIR and UV studies suggested that no bond formation had occurred between the polymer and the drug. DSC and XPRD results ruled out any interaction or complex formation between the drug and the polymer. The formulated SD had acceptable physicochemical characters and SD with a 1 : 4 drug : Polymer ratio, which released the drug over an extended period of eight-to-ten hours. The data obtained from the in vitro release studies were fitted with various kinetic models and were found to follow the Korsmeyer-Peppas equation. The prepared SD showed good stability over the studied time period. The solvent evaporation method was found to be more helpful than the closed melt method, giving the sustained release action. The SD with a 1 : 4 ratio of drug to polymer, by the solvent evaporation method, was selected as the most effective candidate for the subsequent development of a well-timed, sustained-release dosage form of the drug. Medknow Publications 2011 /pmc/articles/PMC3159272/ /pubmed/21897658 http://dx.doi.org/10.4103/0975-1483.83758 Text en © Journal of Young Pharmacists http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Pharmaceutics Jagdale, SC Patil, SA Kuchekar, BS Chabukswar, AR Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion |
title | Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion |
title_full | Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion |
title_fullStr | Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion |
title_full_unstemmed | Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion |
title_short | Preparation and Characterization of Metformin Hydrochloride — Compritol 888 ATO Solid Dispersion |
title_sort | preparation and characterization of metformin hydrochloride — compritol 888 ato solid dispersion |
topic | Pharmaceutics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159272/ https://www.ncbi.nlm.nih.gov/pubmed/21897658 http://dx.doi.org/10.4103/0975-1483.83758 |
work_keys_str_mv | AT jagdalesc preparationandcharacterizationofmetforminhydrochloridecompritol888atosoliddispersion AT patilsa preparationandcharacterizationofmetforminhydrochloridecompritol888atosoliddispersion AT kuchekarbs preparationandcharacterizationofmetforminhydrochloridecompritol888atosoliddispersion AT chabukswarar preparationandcharacterizationofmetforminhydrochloridecompritol888atosoliddispersion |